Metropsis

Visual Function Assessment for Clinical Research

A complete toolbox for psychophysical assessment of visual function

Fast, accurate, and more sensitive than standard tests

For normal, defective, paediatric, ageing and low vision populations

How we work with you

‘Beyond providing a set of well-designed and easy to administer tests of vision, the Metropsis system is a powerful tool for researchers. With Katia’s expert guidance, we have created new measurements, and readily integrated the Metropsis into experiments that record EEG.’ 

Professor Geoffrey Aguire

Uninversity of Pennsylvania

Metropsis is a complete toolbox

Metropsis is a complete test suite suitable for clinical, pre-clinical, drug trials, screening, sports science, applied vision and human factors research. Choose from a wide range of tests, including protocols designed for normal, paediatric, ageing and low vision populations – or we can develop a custom test  for your project.

ETDRS

Easy screening of Best Corrected Visual Acuity using the familiar chart.

Single Optotype

A finer scale of letter sizes allows detection of more subtle changes in visual acuity.

Landolt C

Especially suitable for pre-readers, illiterates and subjects unfamiliar with the Latin alphabet.

Contrast Sensitivity

For a more detailed characterisation of spatial visual abilities.

Pelli-Robson

Quick, easy and efficient to score, measures contrast acuity using customised spatial frequencies.

Cambridge Colour Test

Rapid screening, or full assessment of changes in colour discrimination.

lvv Cambridge Colour Test

Uses a larger stimulus size which is more suitable for patients with low vision.

Universal Colour Discrimination Test

A discrimination task which is simple enough even for children as young as 5 years old.

Peripheral Contrast Sensitivity

For a fine assessment of peripheral vision.

Disability Glare

For measurements of visual function under the effect of glare.

for faster more precise assessment of visual function

Metropsis is more sensitive than standard charts: ideal for investigating diseases of the eye and brain, as well as secondary effects of systemic disorders, such as cardiovascular disease or neurological function.

Metropsis Research 2.0 includes Metropsis Display++ technology (the screen displaying the ETDRS chart above) with a unique integrated sensor system, enabling the display to self-calibrate in real time. So you can be sure that your results are reliable and repeatable – even when performing long-term studies using multiple Metropsis systems across different sites.

trusted worldwide

Metropsis is currently being used in clinical trials and natural history studies in research centres worldwide, including:

  • Moorfields Eye Hospital, London
  • Nuffield Laboratory of Ophthalmology, Oxford
  • National Eye Institute, Bethesda
  • Johnson & Johnson Vision Care
  • Department of Clinical Neurosciences, University of Cambridge
  • Kobe Eye Centre
  • Tokyo Medical Centre
  • L V Prasad Eye Institute, Hyderabad
  • Kellogg Eye Centre, Ann Arbor
  • Institut de la Vision, Paris
  • Institute for Ophthalmic Research, Tubingen

 

  • Emory Eye Centre, Atlanta
  • Department of Ophthalmology, University of Colorado
  • Department of Medicine and Optometry, Linnaeus University
  • Faculty of Medicine, University of Coimbra
  • University of Pennsylvania
  • University of Nevada, Reno
  • Azienda Ospedale Universita’ Padova, Oculistica Ospedale Sant’Antonio Padova, Centro di Ipovisione, Riabilitazione ortottica e Neuroftalmologia
  • University of Latvia
  • Karolinska Institutet, Stockholm
  • Technological University Dublin

Contact us to arrange a personal demo:

Contact Dr Ripamonti

See you at ARVO 2025
booth 1725

Contact Dr Ripamonti

to arrange your personal on-line demonstration

Metropsis is ideal for clinical, longitudinal and drug trials:

age-related macular degeneration
glaucoma
diabetes
multiple sclerosis
peripheral visual loss
astigmatic error
cateract
side effects of prescription drugs
dry eye

retinal pigment epithelial atrophy
cardiovascular disease
neurodegenerative disease
genetic role in photo-transduction cascade
typical acquired colour vision deficiencies
normal ageing
exposure to chemicals
ocular hypertension
drusen

optic neuritis
myopia
glare
mobility
sports
face recognition
driving
light and dark adaptation
neural age-related loss